Company intelligence / Profile preview
Kalbe Farma
- Ownership
- Private
- Employees
- ~16235
- Development stage
- Commercial
Overview
Kalbe Farma is the largest publicly-listed pharmaceutical company in Southeast Asia with a diverse portfolio of marketed products across prescription pharmaceuticals, consumer health, nutritionals, and distribution and logistics divisions.
- Therapeutic areas
- OncologyOphthalmologyImmunologyWomen's HealthHematologyInfectious Diseases
- Modalities
- Small moleculesBiosimilarsMonoclonal antibodiesFusion proteinsColony-stimulating factorsInterferons
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Kalbe Farma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kalbe Farma.